Literature DB >> 11461940

Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes.

Elissa J Schwartz1, Andrea Cara2, Hans Snoeck3, Michael D Ross1, Masaaki Sunamoto1, Jochen Reiser4, Peter Mundel4, Paul E Klotman1.   

Abstract

Human immunodeficiency virus-associated nephropathy (HIVAN) affects up to 10% of HIV-positive black adults and children and is the leading cause of renal disease in infected individuals. The disease is characterized by proliferation of renal epithelial cells, both glomerular and tubular. Diseased kidneys are enlarged, and glomerular visceral epithelial cells (podocytes) express proliferation markers. In a transgenic murine model of HIVAN expressing a deletion construct of HIV-1, the identical pathologic features are observed. It was demonstrated that HIV-1 mRNA is expressed in renal epithelium of the transgenic mouse and in patients with HIVAN, suggesting a direct role for HIV-1 in disease pathogenesis in both humans and the murine model. For investigating the mechanisms responsible for proliferative changes in podocytes, the HIV-1 transgenic mouse was bred onto the immortomouse background, and conditionally immortalized transgenic and nontransgenic podocyte cell lines were established. Transgenic podocytes demonstrated increased spontaneous proliferation, compared with nontransgenic podocytes at confluence, and they were found to have a greater percentage of cells in the proliferative phase of the cell cycle. It is striking that transgenic podocytes were not contact inhibited and formed aggregates in soft agar. Aggregates also formed when nontransgenic podocytes were infected with the identical HIV-1 construct used to generate the transgenic model. This demonstrates that the loss of contact inhibition is due to a direct effect of HIV-1. Therefore, proliferation induced by HIV-1 gene expression is likely to play a key role in the pathogenesis of HIVAN.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461940     DOI: 10.1681/ASN.V1281677

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

1.  Glomerular MYH9 expression is reduced by HIV-1.

Authors:  Thomas Hays; Vivette D D'Agati; Jonathan A Garellek; Tjani Warren; Marc E Trubin; Deborah P Hyink; John Cijiang He; Paul E Klotman
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

2.  Activation of adenosine 2A receptors preserves structure and function of podocytes.

Authors:  Alaa S Awad; Michael Rouse; Lixia Liu; Amy L Vergis; Diane L Rosin; Joel Linden; John R Sedor; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

Review 3.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

Review 4.  What has the immune system got against the glomerular podocyte?

Authors:  P W Mathieson
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy.

Authors:  Scott Martinka; Leslie A Bruggeman
Journal:  Am J Physiol Renal Physiol       Date:  2005-10-04

Review 6.  HIV-associated nephropathy: pathogenesis.

Authors:  Raj K Medapalli; John C He; Paul E Klotman
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

7.  Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy.

Authors:  Madhulika Sharma; Lynn K Magenheimer; Trisha Home; Karen N Tamano; Pravin C Singhal; Deborah P Hyink; Paul E Klotman; Gregory B Vanden Heuvel; Timothy A Fields
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

8.  Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Authors:  Xiaobei Feng; Ting-Chi Lu; Peter Y Chuang; Wei Fang; Krishna Ratnam; Huabao Xiong; Xinshou Ouyang; Yuhong Shen; David E Levy; Deborah Hyink; Mary Klotman; Vivette D'Agati; Ravi Iyengar; Paul E Klotman; John C He
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

9.  Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS).

Authors:  Stephen Tonna; Savita V Dandapani; Andrea Uscinski; Gerald B Appel; Johannes S Schlöndorff; Kang Zhang; Bradley M Denker; Martin R Pollak
Journal:  Gene       Date:  2007-12-03       Impact factor: 3.688

Review 10.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.